Trial Profile
A phase I trial of abemaciclib in combination with pembrolizumab across multiple tumour types
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Abemaciclib (Primary) ; Pembrolizumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 14 Dec 2015 New trial record